Daklinza - Approved Treatment for Chronic Hepatitis C Virus Infection

Image credit: drugdevelopment-technology.com

What is Daklinza used for?

Daklinza is an antiviral medicine that prevents hepatitis C virus (HCV) from multiplying in your body. Daklinza is used in combination with other medications to treat chronic hepatitis C in adults. Daklinza treats specific genotypes of hepatitis C, and only in certain people. Use only the medications prescribed for you.

Can I take Daklinza If I have hepatitis C?

Daklinza treats specific genotypes of hepatitis C, and only in certain people. Use only the medications prescribed for you. Do not share your medicine with other people. Daklinza must be given in combination with other antiviral medications and should not be used alone. It is usually given with sofosbuvir, with or without ribavirin.

Can I take Daklinza with other medicines?

When taking Daklinza with other medicine: To make sure all medicines are safe for you, tell your doctor about all your medical conditions, and if you are pregnant or breastfeeding. Many drugs can interact and cause dangerous effects. Some drugs should not be used together with daclatasvir. Your doctor may change your treatment plan if you also use:

What is Daklinza & Sovaldi used for?

Daklinza and Sovaldi have been used in HCV genotypes 1, 2, 3, and 4 (including in people with HIV/HCV coinfection) and before and after liver transplantation. People with cirrhosis may need longer treatment with Daklinza and Sovaldi, or a third drug called ribavirin (RBV), which is taken twice daily with food.

Is Daklinza a hepatitis C NS5A inhibitor?

Daklinza (daclatasvir) is a hepatitis C virus (HCV) NS5A inhibitor indicated for use with sofosbuvir for the treatment of chronic HCV genotype 3. What Are Side Effects of Daklinza? drowsiness. The recommended dose of Daklinza is 60 mg taken orally once daily with or without food in combination with sofosbuvir for 12 weeks.

When does daclatasvir (Daklinza) become available?

Authority required (written or by phone) From 1 March 2016 daclatasvir (Daklinza), became available on the PBS General Schedule ‘Section 85’ and Section 100 (S100) Highly Specialised Drugs (HSD) Program for oral combination treatment with sofosbuvirfor patients who are 18 years or older with:5

What Is Daklinza

1. https://www.drugs.com/daklinza.html
2. https://en.wikipedia.org/wiki/Daclatasvir
3. https://www.rxlist.com/daklinza-drug.htm
4. https://www.webmd.com/drugs/2/drug-169307/daklinza-oral/details
5. https://www.treatmentactiongroup.org/publication/daklinza-fact-sheet/
6. https://www.medicinenet.com/daclatasvir/article.htm
7. https://medbroadcast.com/drug/getdrug/daklinza
8. https://www.ema.europa.eu/en/documents/overview/daklinza-epar-summary-public_en.pdf
9. https://my.clevelandclinic.org/health/drugs/19535-daclatasvir-tablets
10. https://www.netdoctor.co.uk/medicines/infection/a8929/daklinza-daclatasvir/

Daklinza Information

1. https://www.tga.gov.au/sites/default/files/auspar-daclatasvir-dihydrochloride-151214-pi.pdf
2. https://www.nps.org.au/radar/articles/daclatasvir-with-sofosbuvir-with-or-without-ribavirin-for-chronic-hepatitis-c
3. https://www.healthdirect.gov.au/medicines/brand/amt,729431000168109/daklinza
4. https://go.drugbank.com/drugs/DB09102